Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose apixaban to prevent thrombosis during long-haul flights
2023-000170-97Phase 3Active
- Sponsor
- LMU Klinikum
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of apixaban in deep vein thrombosis (DVT), sponsored by LMU Klinikum. Primary endpoint: Occurrence of clinically relevant leg vein thrombosis. Started Jan 2023; status: active.
02
Drugs
apixaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on 2023-000170-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-000170-97.